Trial ID
PLX124-03
Sponsor ID
Plexxikon Inc.
A Multicenter, Open-Label, Parallel, Phase 2a Study of PLX2853 Monotherapy in Advanced Gynecological Malignancies with a Known ARID1A Mutation and Phase 1b/2a Study of PLX2853/Carboplatin Combination Therapy in Platinum-Resistant Epithelial Ovarian Cancer
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
21369
Sponsor ID
PICCOLO
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
Principal Investigator
Robert L. Marsh, MD
3 Locations
Trial ID
21308
Sponsor ID
Zentalis Pharmaceuticals
A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN‑c3 in Combination with Niraparib in Subjects with Platinum-Resistant Ovarian Cancer
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location